Evidence map›Paper›PMID 30349261›Full record

ArticleNeuropsychiatric disease and treatment2018

Enduring effects of a 5-week behavioral activation program for subthreshold depression among late adolescents: an exploratory randomized controlled trial.

Koki Takagaki, Yasumasa Okamoto, Ran Jinnin, Asako Mori, Yoshiko Nishiyama, Takanao Yamamura, Satoshi Yokoyama, Syouichi Shiota, Yuri Okamoto, Yoshie Miyake and 6 more

Open access · goldAbstract read
In one paragraph

Article in Neuropsychiatric disease and treatment, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
1.6field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 20 citations in OpenAlex.

  1. Behavioural activation therapy for depression in adults.The Cochrane database of systematic reviews · 2020
    Pooled it
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 6 institutions in 1 country.

Koki TakagakiHealth Service Center, Hiroshima, Japan.
Yasumasa OkamotoDepartment of Psychiatry and Neurosciences, Hiroshima University, Hiroshima, Japan, oy@hiroshima-u.ac.jp.
Ran JinninDepartment of Psychiatry and Neurosciences, Hiroshima University, Hiroshima, Japan, oy@hiroshima-u.ac.jp.
Asako MoriDepartment of Psychiatry and Neurosciences, Hiroshima University, Hiroshima, Japan, oy@hiroshima-u.ac.jp.
Yoshiko NishiyamaHaruma City Office, Haruma, Japan.
Takanao YamamuraKanazawa University Hospital Neuropsychiatry, Kanazawa, Japan.
Satoshi YokoyamaDepartment of Psychiatry and Neurosciences, Hiroshima University, Hiroshima, Japan, oy@hiroshima-u.ac.jp.
Syouichi ShiotaJapan Society for the Promotion of Science, Tokyo, Japan.
Yuri OkamotoHealth Service Center, Hiroshima, Japan.
Yoshie MiyakeHealth Service Center, Hiroshima, Japan.
Akiko OgataDepartment of Psychology, Hiroshima University, Hiroshima, Japan.
Yoshihiko KunisatoDepartment of Psychology, School of Human Sciences, Senshu University, Kawasaki, Japan.
Haruki ShimodaDepartment of Hygiene and Preventive Medicine, School of Medicine, Iwate Medical University, Morioka, Japan.
Norito KawakamiDepartment of Psychiatry of Mental Health, The University of Tokyo, Tokyo, Japan.
Toshi A FurukawaDepartment of Health Promotion and Human Behavior and of Clinical Epidemiology, Kyoto University Graduate School of Medicine/School of Public health, Kyoto, Japan.
Shigeto YamawakiDepartment of Psychiatry and Neurosciences, Hiroshima University, Hiroshima, Japan, oy@hiroshima-u.ac.jp.
Hiroshima University · JPIwate Medical University · JPJapan Society for the Promotion of Science · JPKanazawa University Hospital · JPNumazu City Hospital · JPSenshu University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundNo significant effect of psychological treatment has been reported from meta-analysis of subthreshold depression patients and control subjects at 1-year follow-up. However, behavioral activation is a simpler and more cost-effective treatment than cognitive behavioral therapy. The primary purpose of this study was to assess by comparison to an assessment-only control group whether the effects of behavioral activation program for depressive symptoms can persist up to 1-year follow-up without the use of antidepressants or other psychotherapy. PATIENTS AND

methodsLate adolescent students were the population targeted in this study. Participants were allocated randomly to an intervention group (n=62) or a control group (n=56). Treatment consisted of five-weekly 60-minute sessions. Participants underwent a structured interview and completed self-report scales at 1 year post-assessment.

resultsLate adolescent students receiving treatment had significantly lower mean Beck Depression Inventory, second edition scores at 1-year follow-up than control group students. The effect size (Hedges'

conclusionOur behavioral activation program is simple and short. Nevertheless, the results obtained at 1-year follow-up of the control group and late adolescent students receiving treatment indicated a significant difference in their Beck Depression Inventory, second edition scores. Our 5-week behavioral activation program based on behavioral characteristics for subthreshold depression might be promising for subthreshold depression. The sample examined for this study imposed some study limitations.

Indexed as

behavioral activationfirst-year university studentsrandomized controlled trialsubthreshold depression

Identifiers

PMID30349261
PMCPMC6186299
OpenAlexW2894548140

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.